Transcutaneous immunization using common chemicals

被引:20
作者
Karande, Pankaj [2 ]
Arora, Anubhav
Pham, Thien Kahn [1 ]
Stevens, Daniel [1 ]
Wojicki, Arthur [1 ]
Mitragotri, Samir [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA
[2] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA
关键词
High throughput screening; Chemical enhancers; Adjuvanticity; Vaccination; Immunization; Needle-free; PORCINE EAR SKIN; INTRADERMAL DELIVERY; IMMUNE-RESPONSES; VACCINE DELIVERY; IN-VITRO; INTERLEUKIN-1; IRRITATION; MODEL; ABSORPTION; ADJUVANT;
D O I
10.1016/j.jconrel.2009.05.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Transcutaneous immunization, topical application of vaccines on skin, provides several advantages over needle based immunization. However, simple topical application of vaccines does not generate sufficient immune response due to limited transport of vaccines across the stratum corneum of skin. Here we report that chemicals used in common skin products can enhance the immunogenicity of topically applied antigens. Six hundred formulations of commonly used chemicals were screened systematically for their potency (delivery of antigen) in vitro. A selected subset of these formulations was subsequently tested for their adjuvanticity (activation of immune response) in vitro. Lead formulations were tested in vivo for their ability to generate antibody titers against topically applied ovalbumin, a model antigen. Lead formulations were significantly more effective in generating anti-ovalbumin IgG titers. Our results demonstrate that chemical formulations can be successfully used to deliver antigens and that such formulations can be rationally designed by combinatorial screening of individual chemical components. (C) 2009 Elsevier B.V. All rights reserved
引用
收藏
页码:134 / 140
页数:7
相关论文
共 39 条
[1]   Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines [J].
Alarcon, Jason B. ;
Hartley, Andrea Waterston ;
Harvey, Noel G. ;
Mikszta, John A. .
CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (04) :375-381
[2]   Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery [J].
Babiuk, S ;
Baca-Estrada, M ;
Babiuk, LA ;
Ewen, C ;
Foldvari, M .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (2-3) :199-214
[3]   Vaccine delivery: lipid-based delivery systems [J].
Baca-Estrada, ME ;
Foldvari, M ;
Babiuk, SL ;
Babiuk, LA .
JOURNAL OF BIOTECHNOLOGY, 2000, 83 (1-2) :91-104
[4]   IL-1α and IL-1ra secretion from epidermal equivalents and the prediction of the irritation potential of mild soap and surfactant-based consumer products [J].
Bernhofer, LP ;
Barkovic, S ;
Appa, Y ;
Martin, KM .
TOXICOLOGY IN VITRO, 1999, 13 (02) :231-239
[5]   Endogenous interleukin-1 alpha is associated with skin irritation induced by tributyltin [J].
Corsini, E ;
Bruccoleri, A ;
Marinovich, M ;
Galli, CL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 138 (02) :268-274
[6]   Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device [J].
Cui, ZR ;
Baizer, L ;
Mumper, RJ .
JOURNAL OF BIOTECHNOLOGY, 2003, 102 (02) :105-115
[7]   PIG EAR SKIN AS AN INVITRO MODEL FOR HUMAN SKIN PERMEABILITY [J].
DICK, IP ;
SCOTT, RC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (08) :640-645
[8]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[9]   Coated microneedles for transdermal delivery [J].
Gill, Harvinder S. ;
Prausnitz, Mark R. .
JOURNAL OF CONTROLLED RELEASE, 2007, 117 (02) :227-237
[10]   Needle-free vaccine delivery [J].
Giudice, EL ;
Campbell, JD .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (01) :68-89